REGN vs WEST · P/E 14, rev $14.34B vs rev $850.7M
Regeneron Pharmaceuticals Inc (REGN) versus Westrock Coffee Company (WEST) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Westrock Coffee Company (WEST) is a packaged foods company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WEST revenue for 2024-12-31 was $850.7M. Net income was -$80.3M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. WEST currently screens at market cap $851.7M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WEST currently screens at market cap $851.7M.
Not investment advice. Open the REGN and WEST stock pages for the full models.
Not investment advice.